학술논문
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
Document Type
Article
Author
Lazarus, R.; Finn, A.; Querton, B.; Corbic Ramljak, I.; Dewasthaly, S.; Jaramillo, J.C.; Dubischar, K.; Krammer, M.; Weisova, P.; Hochreiter, R.; Eder-Lingelbach, S.; Taucher, C.; Bethune, C.; Boffito, M.; Bula, M.; Burns, F.M.; Clark, R.; Dasyam, D.; Drysdale, S.; Faust, S.; Gkrania-Klotsas, E.; Green, C.; Hassanin, H.; Heath, P.; Heer, A.; Helliwell, T.; Hormis, A.; Kalra, P.; Moran, E.; Ndikum, J.; Page, I.; Price, D.; Probert, N.; Ramjee, M.; Rampling, T.; Randeva, H.S.; Ryder, S.; Steer, J.; Thompson, E.; Torku, D.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, December 2022, 22(12):1716-1727)
Subject
Language
English
ISSN
14744457
14733099
14733099